AI-POWERED CANCER ANALYSIS IN MINORITY WOMEN
OncoEquity harnesses artificial intelligence and health data analytics to identify breast cancer risks early and reduce disparities affecting minority women across communities.
Innovative Technology Meets Healthcare Equity
Our advanced data-driven approach integrates cutting-edge AI with comprehensive health analytics to improve breast cancer outcomes specifically for minority populations, fostering measurable progress in healthcare equity.
OncoEquity is a health-technology initiative focused on leveraging artificial intelligence and advanced data analytics to address inequalities in healthcare outcomes. By combining technology, research, and global health perspectives, the organisation seeks to develop tools that support clinicians, researchers, and institutions in understanding complex healthcare challenges.
Health inequities remain a major global issue. According to the World Health Organization, disparities in access to diagnosis, treatment, and healthcare resources significantly affect patient outcomes across different populations.
OncoEquity aims to contribute to addressing these challenges by developing technology-driven solutions that improve insights into healthcare data and support evidence-based decision making.
2.5M+
women diagnosed with cancer in a year
1.5M
Preventable deaths a year
5%
Of funding directed to areas where cancer is a great burden
Advanced AI Analytics
Utilising machine learning models tailored to identify subtle risk factors among minority women for early intervention.
Targeted Health Data
Comprehensive datasets focusing on underserved populations to ensure relevant and accurate cancer risk assessments.
Inclusive Research Focus
Collaborating closely with diverse healthcare providers and advocacy groups to drive impactful outcomes.
Get in touch
Telephone: +447412842273
E-mail: founder@oncoequity.com
Address: Manchester